Opioids only provide small, short-lasting relief or are ineffective for many acute pain conditions, an overview of systematic ...

Chronic pain often gets the spotlight, but acute pain matters, too. Pain after surgery or an injury isn’t something to ignore or “power through” with the expectation that it’ll eventually go away.

Intravenous morphine plus acetaminophen provides greater early pain reduction and requires fewer rescue doses than morphine alone in the emergency department, a trial finds.

Most patients do not receive important treatment during and after surgery A paper published on Friday by Lancet Africa provides disturbing insight into the way acute pain is managed in South African ...

A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.

Credit: Getty Images Researchers assessed the safety and efficacy of suzetrigine, a non-opioid pain signal inhibitor, on moderate to severe acute pain from in patients with surgical and nonsurgical ...

The world's largest review of opioid pain relievers prescribed for acute pain found these medicines provide only small, short-term relief for some acute conditions and are ineffective for some others.

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

Vertex Pharmaceuticals (VRTX) announced data from a Phase 4 study of JOURNAVX, a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults, that ...

If you’ve ever twisted your ankle, accidentally cut yourself, or had a toothache, you’ve probably experienced acute pain — a temporary sensation that usually comes on suddenly and can be intense.

Millions of Americans live with joint pain caused by everything from repetitive movements like bending and squatting to ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...